Progyny, Inc. Form 8-K Summary
Business Context and Reporting Period
Progyny, Inc. (PGNY), a Delaware corporation, filed this Current Report on Form 8-K on May 8, 2023. The filing announces the financial results for the fiscal quarter ended March 31, 2023. The company's principal executive offices are located in New York, New York.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release furnished as Exhibit 99.1, which is incorporated by reference but not detailed in the body of this 8-K document.
Material Changes
No material changes versus the prior comparable period are described in the text of this filing. The document serves solely as a notification that the Q1 2023 results have been issued via a separate press release.
Guidance, Outlook, and Risks
The filing does not contain management commentary, forward-looking guidance, risk factors, or details on contingencies and unusual items. It explicitly states that the information furnished under Item 2.02 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and shall not be deemed incorporated by reference into other SEC filings.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated May 8, 2023) for actual Q1 2023 financial figures.
- Verify the company's status as an emerging growth company (indicated as not applicable in this filing).
- Confirm the trading symbol (PGNY) and exchange (Nasdaq Global Select Market).
- Note that the 8-K text itself does not contain the financial data required for analysis.